SEC Form D filing

EPALEX Corp, 2025-11-10

An SEC Form D private-offering notice from Mountain View, CA, a $3,199,991 filer-stated offering target in Biotech. Filed 2025-11-10. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

EPALEX Corp site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing novel therapies for migraine and drug-resistant epilepsy.

Filed 2025-11-10Filed to raise $3,199,991First money in 2025-10-31Raised so far $1,200,000HQ (as filed) Mountain View, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified epalex.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source